Peripheral Artery Disease (PAD) Archives

Guidelines for the management of peripheral artery and aortic diseases

Presented By

Prof. Lucia Mazzolai; Prof. José Rodríguez Palomares; Prof. Alessandro Della Corte

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 13:41

Nicotinamide riboside shows promising trend for walking function in PAD

Presented By

Prof. Mary McDermott, Northwestern University, USA

Trial

Phase 2, NICE

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:43

Pemafibrate reduces microvascular complications of PAD and T2D

Presented By

Dr Aruna Pradhan, Brigham and Women’s Hospital, USA

Trial

Phase 3, PROMINENT

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 13:39

How to manage arterial thrombosis and thromboembolism in COVID-19?

Expert

Dr Gregory Lip, Liverpool Heart and Chest Hospital, UK

21 August 2023 15:12

New VOYAGER PAD data: Should patients with both PAD and CKD get rivaroxaban?

Presented By

Dr Mark Svet, University of Colorado, USA

Trial

VOYAGER-PAD

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 15:24

LIBERTY 360 shows quality-of-life improvements after peripheral vascular intervention

Presented By

Dr Mohsin Chowdhury, Harvard Medical School, USA

Trial

LIBERTY 360

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 15:46

Deficient treatment outcomes after PVI in Black and low-income adults with PAD

Presented By

Dr Anna Krawisz, Beth Israel Deaconess Medical Center, MA, USA

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 15:39

REDUCE-IT: Cardiovascular risk reduction with icosapent ethyl in PAD

Presented By

Dr Deepak Bhatt, Brigham and Women’s Hospital, Boston, USA

Trial

Phase 3, REDUCE-IT

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 15:36

VOYAGER PAD: Fragile or diabetic patients also benefit from rivaroxaban

Presented By

Prof. Cecilia Low Wang, University of Colorado, USA

Trial

VOYAGER PAD

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 16:24

Rivaroxaban reduces total ischaemic events after peripheral artery revascularisation

Presented By

Dr Rupert Bauersachs, Klinikum Darmstadt, Germany

Trial

VOYAGER PAD

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 22:13

PAD: Rivaroxaban reduces VTE risk after revascularisation

Presented By

Dr Connie Hess; Prof. Judith Hsia

Trial

VOYAGER PAD

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 11:45

Rivaroxaban protects limbs and ischaemic events in CAD-PAD patients

Presented By

Prof. William Hiatt, University of Colorado, USA

Trial

VOYAGER PAD trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 12:57

Rivaroxaban and aspirin effective and safe for PAD patients

Presented By

Prof. Marc Bonaca, University of Colorado, USA

Trial

VOYAGER PAD

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 23:19

Subgroup analysis VOYAGER PAD

Presented By

Prof. W. Hiatt, University of Colorado, USA

Trial

VOYAGER PAD

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 23:17

Similar MACE rates but higher all-cause mortality in PAD patients with diabetes

Trial

EXSCEL

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 16:45

Patients with polyvascular disease significantly undertreated with lipid lowering therapies

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 15:12

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 11:58